Global Pentavalent Vaccine Market- Industry Analysis, Growth, Segmentation And Forecast-2020-2026

>

Global Pentavalent Vaccine Market- Industry Analysis, Growth, Segmentation and Forecast-2020-2026

The Global Pentavalent Vaccine Market was valued $xx Mn in 2019 and is expected to reach $xx Mn by 2026, at a CAGR of xx%.
Market Introduction and Overview

The pentavalent vaccine is a fully liquid vaccine. It combines five antigens for protection against potentially life-threatening childhood diseases: diphtheria, tetanus, pertussis, hepatitis B, and illnesses caused by Haemophilus influenzae type B.

The fully liquid vaccine is currently a component of national immunization schedules in at least 65 countries eligible to receive vaccines through the GAVI Alliance. Corynebacterium diphteriae is a bacterium which can cause myocarditis (inflammation of the heart muscle), inflammation of nerves and kidney problems. It is transmitted by contact, by contaminated objects or through the air. According to World Health Organization (WHO) data, incidence of diphtheria is on the rise: countries reported more than 7,000 cases in 2016, and almost 17,000 in 2018. Death occurs in 5% to 10% of those infected, mainly in children under 5 years of age.

The increasing prevalence of Diphtheria, Tetanus, Pertussis and Hepatitis B is growing the market of pentavalent vaccine rapidly. Pentavalent vaccine brings cost savings in terms of equipment, delivery and disposal programmes. Investments of emerging manufacturers in the market is considerable and includes sourcing of component vaccines, technology transfers, clinical and analytical development, registration and prequalification activities as well as building manufacturing capacity to meet increasing demand.
Drivers for the Pentavalent Vaccine Market

• Market interventions including technical support by the WHO to manufacturers, technical assistance to several manufacturers facilitated through PATH and funded by the BMGF are intended to increase production efficiencies and improve production economics, primarily for the older manufacturing methods for DTwP.
• In 2019, Panacea Biotech bagged orders worth USD 24.32 million (over Rs 170 crore) from UN agencies, including UNICEF, for the supply of pentavalent vaccine. Panacea Biotech has received awards worth USD 24.32 million from UN agencies (Unicef and PAHO) for supply of its Easyfive-TT, a fully liquid WHO prequalified wP-based Pentavalent vaccine (DTwPHepB-Hib).
• UNICEF anticipates total aggregate pentavalent vaccine forecast demand up to 2019 to reach 449 million doses, averaging 150 million doses a year.
• Entry of new vaccine developers in the market.
• Robust Research and Development factors.
Segment Analysis

Pentavalent (DTP-Hep B-Hib) vaccines are available in both the liquid and freeze-dried forms. However in the freeze-dried form combined DTP-Hep B is available in liquid form and Hib component as freeze dried and therefore the latter should be reconstituted (mixed) before use. It has been decided to use liquid form Pentavalent (DTP-HepB-Hib)vaccine in the national EPI programme considering the convenience of using liquid form of Pentavalent (DTP-HepB-Hib)vaccine at busy immunization clinics,.

At present, only single dose liquid form Pentavalent (DTP-HepB-Hib) vaccine is available. The Hib vaccines in various formulation are licensed in India for almost a decade and widely used in the private sector. Longer shelf life, precise composition and high effectiveness of the powdered form are expanding the segment growth.

The pharmacy retail market in India has witnessed significant growth over the past few years, owing to favourable demographic factors and an epidemiological transition. Rise in patient care initiatives by retail pharmacies. Patients prefer purchasing drugs from retail pharmacies rather than hospitals and therefore, the segment is expected to retain its lead throughout the forecast period.

Global Pentavalent Vaccine Market

Global Pentavalent Vaccine Market

To know about the Research Methodology :- Request Free Sample Report
Regional Insights

Global Pentavalent Vaccine Market1

North America accounted for the largest market share of xx% in 2020 and is expected to grow a CAGR of xx% in the forecast period. Growth in insurance coverage, presence of centres and institutes engaged in R&D and government funding are up surging the North American market. Well-established healthcare infrastructure, ease of availability and increasing immunization program are also key drivers affecting the market growth. Investments by key players in this field has boosted the market growth. Europe is also expected to drive the market and the factors responsible for growth are the growing acceptance of emerging advanced technologies, rising incidence of Hep-B and tetanus.
Asia Pacific is also expected to witness significant growth during the forecast period due to rising health care expenditures. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand. Compulsory and free immunization programs by governments are also driving the market in the region.

Global Pentavalent Vaccine Market2

For More Information Visit @: Maximize Market Research Company

 


Scope of the Report: Inquire before Buying

Global Pentavalent Vaccine Market3
By Region

• North America
• Europe
• South America
• MEA
• Asia Pacific
Key Players Operating in the Global Pentavalent Vaccine Market

• Serum Institute of India
• Panacea Drugs Pvt. Ltd
• Shantha Biotechnics
• Biological E. Ltd.
• Novartis AG

The report also helps in understanding Global Pentavalent Vaccine Market dynamics, structure by analysing the market segments and project the Global Pentavalent Vaccine Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Pentavalent Vaccine Market make the report investor’s guide.

About Us:
Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Share:

Keywords: pentavalent vaccine market

Comments

Other related blogs

KBC Online Winners 25 lakh list - KBC Registration Process | Sony Prize

By : Sony Prize

Here you will find a list of KBC Lottery winners and KBC title variants to receive your KBC Lottery ..


KBC Head Office Number - KBC Lottery Winner CheckList | KBC Official Winner

By : KBC Official Winner

Get all basic stats for kbc lottery winner from the official website. We share important facts about..


KBC Lucky Draw 2021 Winners List - KBC Lottery Process | KBC Lottery Winner

By : KBC Lottery Winner

Check out the list of KBC lottery winners and kbc header numbers to claim your winnings from KBC 25 ..


registration on GeM portal as seller

By : Registration On GeM Portal As Seller

Get GeM registration for the Indian Market Government E Market Place is entirely new. Its complete m..